Table 1 HGLDA was applied to three kinds of important cancer (breast cancer, lung cancer and colorectal cancer).

From: Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA

Disease

lncRNA

Evidence (PMID)

Breast cancer

MALAT1

24525122;19379481

Breast cancer

H19

16707459;14729626;12419837

Breast cancer

CDKN2B-AS1

17440112;20956613

Breast cancer

NEAT1

25417700;23825647

Breast cancer

XIST

17545591

Breast cancer

KCNQ1OT1

21304052

Breast cancer

HOTAIRM1

25296969

Lung cancer

EPB41L4A-AS1 BCYRN1

16973895;9490301

Lung cancer

MALAT1

20937273;24757675;24667321

Lung cancer

TUG1

24853421

Lung cancer

GAS5

24357161;23676682

Lung cancer

HOTAIR

25491133;24591352;24155936

Lung cancer

H19

16707459;8838103;7700644

Lung cancer

NEAT1

25010625

Colorectal cancer

XIST

17143621;22879877

Colorectal cancer

HOTAIR

24531795;21862635;24667321

Colorectal cancer

MALAT1

21503572;25446987;25031737

Colorectal cancer

KCNQ1OT1

16965397;11340379;23660942

Colorectal cancer

H19

18719115;19926638;22121898

  1. As a result, 19 predicted lncRNA-disease pairs with significant FDR less than 0.05 have been confirmed based on recent experimental literatures.
Back to article page